UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$531.82
+10.60 (+2.03%)
Analyst Consensus
Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-83.4% upside
Low Target
$65.70
Average Target
$88.53
High Target
$121.74
Current Price
$531.82
Current
$531.82
$531.82
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Scenario Analysis
Bear Case
$65.70
-87.6%
Low target
Base Case
$88.53
-83.4%
Avg target
Bull Case
$121.74
+-77.1%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$519.99
2.3% from high
52-Week Low
$266.98
+99.2% from low
50-Day SMA
$485.49
+9.5% vs SMA
200-Day SMA
$394.55
+34.8% vs SMA
RSI (14)
60.3
Neutral
Target vs 52W High
$88.53
-83.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +25.5% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.2% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.6% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.6% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -66.8% |
| INSM | Strong Buy | 26 | 92% | $143.40 | +3.1% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -26.5% |